One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...

The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...

On August 1, 2023, the US Secretary of State Antony Blinken launched the new Bureau of Global Health Security and Diplomacy at the Acheson Auditorium in the State Department. Reorganizing government is unglamorous and rife with political hazards, but it has the potential to build a faster and better...

Despite the vivid challenges of the early phase of the COVID-19 pandemic, the world remains unprepared to manufacture and distribute vaccines for the next large health emergency or pandemic. Although the global response to COVID-19 has seen major advances in vaccine technology and distribution, it h...

While oral antivirals are not a substitute for vaccination, they help prevent severe illness, save lives, and preserve health systems. Vaccination rates continue to lag in low-income countries: only 14 percent of the population in low-income countries has received one dose of the vaccine, compared t...

Last week, the European Union and its member states placed a “European global health strategy” at the top of their shared agenda. And as part of the EU-Africa summit this week in Brussels, the EU is highlighting its support for regional manufacturing of COVID-19 vaccine via the African Union’s Partn...